Mary Cianfrocca

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Richard G. Margolese, Reena S. Cecchini, Thomas B. Julian et al. · The Lancet · 2015 · 195 citations

Medicine, Oncology, Pharmacology +12

Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcoma

Mary Cianfrocca, Jamie Von Roenn, Anil Tulpule et al. · Cancer · 2010 · 168 citations · Full text

Medicine, Oncology, Pharmacology +13

Matrix Metalloproteinase Inhibitor COL-3 in the Treatment of AIDS-Related Kaposi's Sarcoma: A Phase I AIDS Malignancy Consortium Study

Mary Cianfrocca · Journal of Clinical Oncology · 2002 · 150 citations

Medicine, Clinical Pharmacokinetics, Oncology +17

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Patricia A. Ganz, Reena S. Cecchini, Thomas B. Julian et al. · The Lancet · 2015 · 79 citations

Medicine, Oncology, Surgery +12

A Phase I and Pharmacokinetic Study of Lapatinib in Combination with Letrozole in Patients with Advanced Cancer

Quincy S. Chu, Mary Cianfrocca, Lori J. Goldstein et al. · Clinical Cancer Research · 2008 · 71 citations

Medicine, Oncology, Pharmacology +17